Balaji Laxmanan

Johnson & Johnson (United States)

Papers

6

Total Citations

170

H-Index

4

About

Balaji Laxmanan is a pulmonologist and clinical researcher whose work centers on interventional pulmonology, with a particular focus on advanced bronchoscopic technologies for the diagnosis of pulmonary lesions. His research has meaningfully advanced the field's understanding of peripheral bronchoscopy, including robot-assisted bronchoscopy (RAB), electromagnetic navigation, and cone beam CT guidance systems. Among his most influential contributions is a 2021 paper examining how alternative approaches to diagnostic yield calculation affect study outcomes in bronchoscopy—a methodologically important work that has garnered over 100 citations and prompted researchers to think more critically about how diagnostic success is measured and reported. Laxmanan has also been a driving force behind real-world and multicenter evaluations of robotic-assisted bronchoscopy, helping to extend findings beyond academic centers into community settings where the majority of patients are treated. His involvement in the prospective TARGET trial further underscores his commitment to rigorous, safety-focused evidence generation for emerging technologies. Collectively, his body of work has accumulated over 170 citations, positioning him as a credible voice shaping how clinicians adopt and evaluate cutting-edge tools for early lung cancer diagnosis.

Research Focus

Key Achievements

4
H-Index
6
Papers
170
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy
104 citations · 2021
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago